Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Timing HIV infection with nonlinear viral dynamics

View ORCID ProfileDaniel Reeves, View ORCID ProfileMorgane Rolland, View ORCID ProfileBethany L Dearlove, Yifan Li, View ORCID ProfileMerlin Robb, View ORCID ProfileJoshua T Schiffer, View ORCID ProfilePeter Gilbert, E Fabian Cardozo-Ojeda, View ORCID ProfileBryan Mayer
doi: https://doi.org/10.1101/2020.08.13.20174243
Daniel Reeves
1Vaccine and Infectious Diseases Division, Fred Hutchinson Cancer Research Center, Seattle WA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Daniel Reeves
  • For correspondence: dreeves@fredhutch.org
Morgane Rolland
2U.S. Military HIV Research Program, Walter Reed Army Institute of Research, Silver Spring, MD, USA
3Henry M. Jackson Foundation for the Advancement of Military Medicine, Bethesda, MD, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Morgane Rolland
Bethany L Dearlove
2U.S. Military HIV Research Program, Walter Reed Army Institute of Research, Silver Spring, MD, USA
3Henry M. Jackson Foundation for the Advancement of Military Medicine, Bethesda, MD, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Bethany L Dearlove
Yifan Li
2U.S. Military HIV Research Program, Walter Reed Army Institute of Research, Silver Spring, MD, USA
3Henry M. Jackson Foundation for the Advancement of Military Medicine, Bethesda, MD, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Merlin Robb
2U.S. Military HIV Research Program, Walter Reed Army Institute of Research, Silver Spring, MD, USA
3Henry M. Jackson Foundation for the Advancement of Military Medicine, Bethesda, MD, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Merlin Robb
Joshua T Schiffer
1Vaccine and Infectious Diseases Division, Fred Hutchinson Cancer Research Center, Seattle WA, USA
4Department of Medicine, University of Washington, Seattle, WA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Joshua T Schiffer
Peter Gilbert
1Vaccine and Infectious Diseases Division, Fred Hutchinson Cancer Research Center, Seattle WA, USA
5Department of Statistics, University of Washington, Seattle, WA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Peter Gilbert
E Fabian Cardozo-Ojeda
1Vaccine and Infectious Diseases Division, Fred Hutchinson Cancer Research Center, Seattle WA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Bryan Mayer
1Vaccine and Infectious Diseases Division, Fred Hutchinson Cancer Research Center, Seattle WA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Bryan Mayer
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Abstract

In HIV prevention trials, precise identification of infection time is critical to quantify drug efficacy but difficult to estimate as trials may have relatively sparse visit schedules. The last negative visit does not guarantee a boundary on infection time because viral nucleic acid is not present in the blood during early infection. Here, we developed a framework that combines stochastic and deterministic within-host mathematical modeling of viral dynamics accounting for the early unobservable viral load phase until it reaches a high chronic set point. The infection time estimation is based on a population non-linear mixed effects (pNLME) framework that includes the with-in host modeling. We applied this framework to viral load data from the RV217 trial and found a parsimonious model capable of recapitulating the viral loads. When adding the stochastic and deterministic portion of the best model, the estimated infection time for the RV217 data had an average of 2 weeks between infecting exposure and first positive. We assessed the sensitivity of the infection time estimation by conducting in silico studies with varying viral load sampling schemes before and after infection. pNLME accurately estimates infection times for a daily sampling scheme and is fairly robust to sparser schemes. For a monthly sampling scheme before and after first positive bias increases to -7 days. For pragmatic trial design, we found sampling weekly before and monthly after first positive allows accurate pNLME estimation. Our estimates can be used in parallel with other approaches that rely on viral sequencing, and because the model is mechanistic, it is primed for future application to infection timing for specific interventions.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

DBR is funded by a Washington Research Foundation postdoctoral fellowship. Funding was also provided by the National Institute of Health NIAID (K25 AI155224 to DBR, UM1 AI068635 to PBG and JTS, R01 AI150500 to EFC and JTS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

RV217

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Footnotes

  • Added some funding information and fixed a middle initial.

Data Availability

All data and computational code are available from the authors and will be posted to github after acceptance.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-ND 4.0 International license.
Back to top
PreviousNext
Posted September 11, 2020.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Timing HIV infection with nonlinear viral dynamics
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Timing HIV infection with nonlinear viral dynamics
Daniel Reeves, Morgane Rolland, Bethany L Dearlove, Yifan Li, Merlin Robb, Joshua T Schiffer, Peter Gilbert, E Fabian Cardozo-Ojeda, Bryan Mayer
medRxiv 2020.08.13.20174243; doi: https://doi.org/10.1101/2020.08.13.20174243
Digg logo Reddit logo Twitter logo Facebook logo Google logo LinkedIn logo Mendeley logo
Citation Tools
Timing HIV infection with nonlinear viral dynamics
Daniel Reeves, Morgane Rolland, Bethany L Dearlove, Yifan Li, Merlin Robb, Joshua T Schiffer, Peter Gilbert, E Fabian Cardozo-Ojeda, Bryan Mayer
medRxiv 2020.08.13.20174243; doi: https://doi.org/10.1101/2020.08.13.20174243

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • HIV/AIDS
Subject Areas
All Articles
  • Addiction Medicine (179)
  • Allergy and Immunology (431)
  • Anesthesia (99)
  • Cardiovascular Medicine (943)
  • Dentistry and Oral Medicine (178)
  • Dermatology (109)
  • Emergency Medicine (260)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (419)
  • Epidemiology (8971)
  • Forensic Medicine (4)
  • Gastroenterology (418)
  • Genetic and Genomic Medicine (1938)
  • Geriatric Medicine (190)
  • Health Economics (400)
  • Health Informatics (1323)
  • Health Policy (657)
  • Health Systems and Quality Improvement (517)
  • Hematology (212)
  • HIV/AIDS (416)
  • Infectious Diseases (except HIV/AIDS) (10772)
  • Intensive Care and Critical Care Medicine (571)
  • Medical Education (200)
  • Medical Ethics (54)
  • Nephrology (221)
  • Neurology (1819)
  • Nursing (108)
  • Nutrition (271)
  • Obstetrics and Gynecology (351)
  • Occupational and Environmental Health (469)
  • Oncology (992)
  • Ophthalmology (296)
  • Orthopedics (111)
  • Otolaryngology (182)
  • Pain Medicine (126)
  • Palliative Medicine (44)
  • Pathology (265)
  • Pediatrics (576)
  • Pharmacology and Therapeutics (275)
  • Primary Care Research (234)
  • Psychiatry and Clinical Psychology (1892)
  • Public and Global Health (4111)
  • Radiology and Imaging (674)
  • Rehabilitation Medicine and Physical Therapy (364)
  • Respiratory Medicine (548)
  • Rheumatology (224)
  • Sexual and Reproductive Health (190)
  • Sports Medicine (177)
  • Surgery (207)
  • Toxicology (38)
  • Transplantation (109)
  • Urology (80)